Display options
Share it on

J Cheminform. 2017 Dec 30;9(1):67. doi: 10.1186/s13321-017-0249-4.

Computer-aided design of multi-target ligands at A.

Journal of cheminformatics

Leen Kalash, Cristina Val, Jhonny Azuaje, María I Loza, Fredrik Svensson, Azedine Zoufir, Lewis Mervin, Graham Ladds, José Brea, Robert Glen, Eddy Sotelo, Andreas Bender

Affiliations

  1. Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Lensfield Road, Cambridge, CB21EW, UK.
  2. Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  3. Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  4. IOTA Pharmaceuticals Ltd, St Johns Innovation Centre, Cowley Road, Cambridge, CB40WS, UK.
  5. Discovery Sciences, AstraZeneca R&D, Cambridge Science Park, Cambridge, UK.
  6. Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB21QJ, UK.
  7. Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, UK.
  8. Center for Research in Biological Chemistry and Molecular Materials (CIQUS), University of Santiago de Compostela, 15782, Santiago de Compostela, Spain. [email protected].
  9. Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Lensfield Road, Cambridge, CB21EW, UK. [email protected].

PMID: 29290010 PMCID: PMC5748027 DOI: 10.1186/s13321-017-0249-4

Abstract

Compounds designed to display polypharmacology may have utility in treating complex diseases, where activity at multiple targets is required to produce a clinical effect. In particular, suitable compounds may be useful in treating neurodegenerative diseases by promoting neuronal survival in a synergistic manner via their multi-target activity at the adenosine A

Keywords: Adenosine receptor ligands; Docking; Drug design; Multi-target ligands; PDE10A inhibitors; QSAR; Target prediction

References

  1. Nucleic Acids Res. 2015 Jul 1;43(W1):W200-7 - PubMed
  2. Bioorg Med Chem. 2009 Aug 15;17(16):5974-82 - PubMed
  3. Purinergic Signal. 2008 Mar;4(1):39-46 - PubMed
  4. J Med Chem. 2011 Jan 27;54(2):457-71 - PubMed
  5. J Med Chem. 2016 Jul 14;59(13):6470-9 - PubMed
  6. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2262-5 - PubMed
  7. J Med Chem. 2010 Apr 8;53(7):2719-40 - PubMed
  8. J Med Chem. 2004 Aug 26;47(18):4517-29 - PubMed
  9. J Med Chem. 2004 Jul 29;47(16):4041-53 - PubMed
  10. J Med Chem. 2015 Oct 8;58(19):7888-94 - PubMed
  11. Science. 2008 Nov 21;322(5905):1211-7 - PubMed
  12. J Med Chem. 2013 Nov 27;56(22):8955-71 - PubMed
  13. J Neurochem. 2001 Nov;79(3):463-84 - PubMed
  14. J Med Chem. 2004 Mar 25;47(7):1750-9 - PubMed
  15. Mol Inform. 2013 Dec;32(11-12):1009-24 - PubMed
  16. PLoS One. 2013;8(4):e60470 - PubMed
  17. Brain. 2015 Oct;138(Pt 10):3003-15 - PubMed
  18. Mol Pharmacol. 2016 Dec;90(6):703-714 - PubMed
  19. Nat Rev Drug Discov. 2009 Jun;8(6):455-63 - PubMed
  20. Nature. 2012 Dec 13;492(7428):215-20 - PubMed
  21. Trends Pharmacol Sci. 2005 Apr;26(4):178-82 - PubMed
  22. J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22 - PubMed
  23. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3738-42 - PubMed
  24. J Med Chem. 2012 Feb 9;55(3):1402-17 - PubMed
  25. J Comput Aided Mol Des. 2007 Dec;21(12):681-91 - PubMed
  26. J Pharmacol Exp Ther. 2008 May;325(2):681-90 - PubMed
  27. J Med Chem. 2016 May 12;59(9):4087-102 - PubMed
  28. Neurobiol Dis. 2009 Jun;34(3):450-6 - PubMed
  29. Front Neurosci. 2016 Jun 10;10:265 - PubMed
  30. Lancet Neurol. 2004 May;3(5):309-16 - PubMed
  31. Bioorg Med Chem. 2006 Aug 15;14(16):5605-15 - PubMed
  32. Bioorg Med Chem. 2016 Aug 15;24(16):3447-55 - PubMed
  33. J Chem Inf Model. 2015 Feb 23;55(2):460-73 - PubMed
  34. J Comput Aided Mol Des. 2013 Mar;27(3):221-34 - PubMed
  35. J Med Chem. 2014 May 8;57(9):3623-50 - PubMed
  36. Mol Cell Biol. 2000 Dec;20(24):9356-63 - PubMed
  37. Int J Biol Sci. 2015 Jul 16;11(9):1100-12 - PubMed
  38. J Med Chem. 2015 Jan 22;58(2):978-93 - PubMed
  39. Eur J Med Chem. 2011 Sep;46(9):3590-607 - PubMed
  40. Eur J Med Chem. 2016 Jan 1;107:97-108 - PubMed
  41. J Cheminform. 2015 Oct 24;7:51 - PubMed
  42. Bioorg Med Chem Lett. 2016 Jan 1;26(1):126-32 - PubMed
  43. Drug Discov Today. 2002 Oct 15;7(20 Suppl):S163-9 - PubMed
  44. J Med Chem. 2015 Oct 22;58(20):8292-308 - PubMed
  45. Ultrason Sonochem. 2012 Sep;19(5):1061-9 - PubMed
  46. Science. 2012 Jul 13;337(6091):232-6 - PubMed
  47. Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7 - PubMed
  48. Pharm Res. 2010 May;27(5):739-49 - PubMed
  49. J Med Chem. 2011 Nov 10;54(21):7621-38 - PubMed
  50. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1376-80 - PubMed
  51. ChemMedChem. 2016 Jun 20;11(12 ):1270-83 - PubMed
  52. Oncotarget. 2015 ;6(12 ):9646-56 - PubMed
  53. J Biol Chem. 1992 Apr 5;267(10):6451-4 - PubMed
  54. J Med Chem. 2016 Feb 11;59(3):947-64 - PubMed
  55. Blood. 2010 Jul 29;116(4):593-602 - PubMed
  56. J Proteomics. 2011 Nov 18;74(12):2554-74 - PubMed
  57. Neurobiol Dis. 2010 Jan;37(1):33-7 - PubMed
  58. Drug Discov Today. 2004 Aug 1;9(15):641-51 - PubMed
  59. Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 - PubMed
  60. Biochim Biophys Acta. 2011 May;1808(5):1380-99 - PubMed
  61. Curr Med Chem. 2002 Dec;9(23):2085-93 - PubMed
  62. J Med Chem. 2008 Aug 14;51(15):4449-55 - PubMed
  63. Bioorg Med Chem Lett. 2016 Sep 1;26(17 ):4216-22 - PubMed
  64. ChemMedChem. 2016 Jun 20;11(12 ):1190-2 - PubMed

Publication Types